-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Verrica Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
- Verrica Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$22.9M, a 7.83% increase year-over-year.
- Verrica Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$85M, a 75.9% decline year-over-year.
- Verrica Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$67M, a 174% decline from 2022.
- Verrica Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$24.5M, a 30.2% increase from 2021.
- Verrica Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$35.1M, a 17.8% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)